Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Plus, the FT’s southeast Europe correspondent, Valerie Hopkins, explains the love-hate relationships that Serbians have with Chinese investment in their country....
...“Our competitors get into these brand wars like Coke v Pepsi,” says Zimmer at UTA....
International Edition